EU Approves First Oral GLP-1 Treatment for Weight Management
The European Commission has approved Wegovy® pill as the EU's first oral…
UAE Becomes a Global Testing Ground for the Weight Loss Pill Everyone’s Talking About
The UAE has become the second country globally to approve oral Wegovy…
Novo Nordisk Collaborates with Vivani Medical to Evaluate Long-Acting Semaglutide Implant
A new collaboration will evaluate a long-acting semaglutide implant for chronic weight…
UAE becomes second country globally to approve Wegovy pill for weight loss
The UAE has become the second country worldwide to approve the oral…
EU Approves Stronger Weekly Injection for Adults with Obesity
A higher-dose obesity injection delivering over 20% average body weight loss has…
Ozempic for Weight Loss: What You Need to Know
Ozempic is a medication originally developed for type 2 diabetes that is…
Lancet Study: Semaglutide Reduces Risk of CV Death and Worsening Heart Failure
PLAINSBORO, N.J- Recently, The Lancet published a new pooled, participant-level analysis of patients…
